Another month has passed since my last post in which I described Cardiogenics as being in a state of rigor mortis. The decay of this company is IMO fast approaching or may have already passed a point of no return.

The only logical explanation for Cardiogenics' failure to provide information regards the outcome of the Beta Site Study is the POC Analyzer failed to perform as expected. I imagine that Dr G's inability to accept this outcome has proven beyond his managment skills to properly inform the company's shareholders. If this is an accurate description of the "state of affairs" within Cardiogenics, we shareholders can only hope that the Board of Directors or Saunders will inform the investing public with the long overdue public announcement of the failed Beta Site Study.

Ante